Learn More About Plantar Fibromatosis and
How Transdermal Verapamil 15% Gel Can Help

What To Expect From Transdermal Verapamil 15% Gel

Treatment Timeline

It is important to understand that there are no "quick fix" treatments for plantar fibromatosis. This is because remodeling tissue is a slow process. Patients should expect to use Transdermal Verapamil 15% Gel for 6 to 12 months to complete their treatment. Patients who are experiencing pain or discomfort typically see this as the first symptom to be significantly improved, usually within 90 days. Once the fibroma has been remodeled, recurrence is unusual. Transdermal Verapamil 15% Gel is not a life long treatment and it is not necessary to use the medication periodically as a maintenance or preventative treatment.

treatment timeline

What Happens If I Am Not Getting Better?

Myth: If I don't see great results in 90 days the medicine will not work for me. Fact: Most patients use the medication 6 to 12 months to achieve successful treatment.

As with any medication, Transdermal Verapamil 15% Gel will not help everyone; however, PDLabs wants to make every effort to maximize the results patients receive. Patients that are not responding tend to fall into one of two categories. First are patients that do not improve at all and patients that have responded but seem to have reached a plateau and no longer improving. All patients are started on a twice a day regimen since this is effective for the majority of patients. If you are not responding at this dose, a PDLabs pharmacist will contact your doctor to discuss alternative doses that have proven effective in other patients that might be appropriate for you.

Side Effects

Side effects for patients treating plantar fibromatosis have been very rare. Due to the highly tolerant nature of the skin on the plantar surface of the foot, the skin irritation seen in Peyronie's disease patients has not been seen in plantar fibromatosis patients. Since verapamil is a medication used to reduce blood pressure when it is taken orally, patients should report any dizziness, sudden rapid heart beat, or unusual irregular or rapid heart beat to PDLabs and/or their doctor.